Chronic Obstructive Pulmonary Disease
A progressive, largely smoking-related obstructive lung disease encompassing chronic bronchitis and emphysema, managed with bronchodilators, inhaled corticosteroids, and, in advanced disease, biologics and oxygen therapy.
Phase 1/2 and later readouts in Chronic Obstructive Pulmonary Disease, in your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
Total attributable cost
$61.4B
$4,322/patient
Drug spend
Not yet sourced
All severities, diagnosed (2022 estimate) · US